Table 2.
Summary of perioperative prevention strategies for opioid abuse.
Preoperative | Reference |
---|---|
Risk factors assessment | |
Substance use disorder (opioids, alcohol, tobacco and others) | [24, 50–52] [29, 49, 54] |
Previous or current opioid use (>50 oral morphine equivalents) | [29] |
Long-acting/extended release opioid formulations | [29] |
Use of benzodiazepines and other sedatives or history of mental illness | [20] |
Arthritis, depression, diabetes, heart failure, and lung disease | [21, 34, 54, 66] |
Low income or living in less developed areas | [21, 35] |
Prescription drug monitoring program for multiple opioid prescriptions or other agents | [29] |
Suggestions | |
Utilization of ERAS | [71] |
Cessation of smoking | [72] |
Education of patients and their families regarding the opioid-related risks, with more consultation service | [73, 74, 75] |
Treatment of the primary disease, such as arthritis, depression, and mental illness | [76] |
Presetting of acceptable postoperative pain level to reduce panic and tension | [29] |
Detailed and well-planed surgical approach | [77] |
Intraoperative | |
Meticulous surgical procedures that minimize nerve damage | [78] |
Advanced intraoperative monitoring | [79, 80] |
Combination of several anesthesia methods and analgesic drugs | [81, 82, 83, 84] |
Utilization of ERAS | [71] |
Postoperative | |
Implementation of educational programs and clinical guidelines on opioid use | [73, 74, 75] |
Utilization of REAS | [71] |
Nerve block technique or epidural blockade for postoperative analgesia | [85, 86] |
Decreased use of opioids and increased use of nonopioid medications for postoperative analgesic, including NSAIDs or opioid substitutes | [81, 82, 87–89] |
Use of naloxone when needed | [90] |
Treatment of primary disease itself especially in patients with mental illnesses | [76] |
Relaxation and minimization of anxiety | [91] |